Literature DB >> 32420948

SARS-CoV-2 infection in children in Parma.

Icilio Dodi1, Eleonora Castellone1, Marco Pappalardo1, Monica Rubini1, Piero Veronese1, Claudio Ruberto1, Laura Bianchi1, Brunella Iovane1, Valentina Maffini1.   

Abstract

not available.

Entities:  

Mesh:

Year:  2020        PMID: 32420948      PMCID: PMC7569611          DOI: 10.23750/abm.v91i2.9563

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


× No keyword cloud information.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), emerged from Wuhan, Hubei province, China, in late 2019 and has now reached pandemic status (1). Coronaviruses typically cause mild upper respiratory tract infections; however, SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV) (3), and Middle East respiratory syndrome coronavirus (MERS-CoV) (4) have all been associated with severe illness and death. Common symptoms reported in adults with COVID-19 are fever, dry cough, and fatigue; severe cases have been associated with dyspnoea and bilateral ground-glass opacities on chest CT. Severe COVID-19 in children is rare. To date, the largest review of children with COVID-19 included 2143 children in China. Only 112 (5,6%) of 2143 children had severe disease (defined as hypoxia) and 13 (0,6%) children developed respiratory or multiorgan failure or acute respiratory distress syndrome (ARDS). Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12–April 2, 2020 were analyzed. Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years. Three deaths were reported among the pediatric cases included in this analysis (5). The Spanish series in Madrid suggesting that only 2% of affected individuals are younger than 19 years and 60% of confirmed infections in children required hospital admission. Twenty five of 41children with confirmed COVID-19 (60%) were hospitalized, 4 of 41 (9.7%)were admitted to a pediatric intensive care unit (PICU), and 4 of 41 (9.7%) needed respiratory support beyond nasal prongs. Of these, 1 of 4 (25%) had only 1 previous condition (recurrent wheezing). No patients died (6). Children are susceptible to SARS-CoV-2 infection, but frequently do not have notable disease, Children with COVID-19 might not have reported fever or cough as often as do adults (7). Paediatric patients with COVID-19 had mild or asymptomatic disease accompanied by pneumonia in about half the cases (8). We evaluated children symptomatic and asymptomatic, with known contact with persons having confirmed or suspected SARS-CoV-2, at the “Barilla Children’s Hospital” of Parma. Nasopharyngeal or throat swabs were obtained for detection of SARS-CoV-2 RNA by established methods (9). The clinical outcomes were monitored up to April 19, 2020. Of the 61 children assessed and tested from 26.02.2020 to 14.04.2020. A total of 14 (23 %) were confirmed to have SARS-CoV-2 infection. Demographic data and clinical features are summarized in Table 1.
Table 1.
Value (n.)Value (%)
SwabTotal61
Positive1422,95
Inpatient4711,47
Epidemiological and clinical characteristics of children with SARS-CoV2 infection
Age
Median22 months
Distribution< 1 year750
01-05 yr321,4
06-10 yr17,14
11-15 yr321,4
SexMale964,28
Female535,71
DiagnosisAsymptomatic infection00
Upper respiratory tract infection14100
Pneumonia00
Contact
Family clusterConfirmed321,4
Suspected750
Non family cluster17,14
Unidentified source428,57
Signs and symptomsFever14100
Cough535,7
Pharyngeal erythema750
Diarrhea214,28
Vomiting214,28
Inappetence321,4
Exanthema214,28
Neurologic symptoms214,28
Fever during hospitalization
Median duration of fever17 hours
Highest temperature< 37,5 °C114,28
37,6 – 38 °C342,8
38,1 – 39 °C114,28
> 39,1 °C228,5
The median age of the infected children was 22 months. Fever was present in 100 of the children with median duration of 17 hours. Other common signs and symptoms included cough (35%) and pharyngeal erythema (50%). Nobody had pneumonia or necessity of oxigen therapy. 1 patient has febrile seizures. 1 patient has anemia and lymphopenia. In contrast with infected adults, infected children appear to have a milder clinical course. Asyntomatic children play a role in a transmission and spread of COVID-19. For this reasons preventive behaviors are recommended for persons of all ages.
  6 in total

Review 1.  Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update.

Authors:  Mark R Denison
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

2.  Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia.

Authors:  Jaffar A Al-Tawfiq; Rana F Kattan; Ziad A Memish
Journal:  World J Clin Pediatr       Date:  2016-11-08

3.  Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population.

Authors:  Litty Varghese; Philip Zachariah; Celibell Vargas; Philip LaRussa; Ryan T Demmer; Yoko E Furuya; Susan Whittier; Carrie Reed; Melissa S Stockwell; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

4.  Notes from the Field: Measles Outbreak Associated with International Air Travel - California, March-April 2017.

Authors:  Lihan Lu; Efrosini Roland; Eric Shearer; Matthew Zahn; Maria Djuric; Eric McDonald; Susan Redd; Kara Tardivel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

5.  Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain.

Authors:  Alfredo Tagarro; Cristina Epalza; Mar Santos; Francisco José Sanz-Santaeufemia; Enrique Otheo; Cinta Moraleda; Cristina Calvo
Journal:  JAMA Pediatr       Date:  2020-04-08       Impact factor: 16.193

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  6 in total
  6 in total

Review 1.  Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies.

Authors:  Kamelia R Stanoeva; Annemiek A van der Eijk; Adam Meijer; Laetitia M Kortbeek; Marion P G Koopmans; Chantal B E M Reusken
Journal:  Euro Surveill       Date:  2021-03

2.  Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.

Authors:  Andrew Robert Barclay; Christina McGuckin; Susan Hill; Sue Protheroe; Akshay Batra
Journal:  Frontline Gastroenterol       Date:  2020-10-27

3.  Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility.

Authors:  Katy A M Gaythorpe; Sangeeta Bhatia; Tara Mangal; H Juliette T Unwin; Natsuko Imai; Gina Cuomo-Dannenburg; Caroline E Walters; Elita Jauneikaite; Helena Bayley; Mara D Kont; Andria Mousa; Lilith K Whittles; Steven Riley; Neil M Ferguson
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

4.  CLINICAL AND LABORATORY CHARACTERISTICS OF SARS-COV-2 INFECTION IN CHILDREN AND ADOLESCENTS.

Authors:  Marlos Melo Martins; Arnaldo Prata-Barbosa; Maria Clara de Magalhães-Barbosa; Antonio José Ledo Alves da Cunha
Journal:  Rev Paul Pediatr       Date:  2020-11-16

Review 5.  Coronavirus global pandemic: An overview of current findings among pediatric patients.

Authors:  Evanthia Perikleous; Aggelos Tsalkidis; Andrew Bush; Emmanouil Paraskakis
Journal:  Pediatr Pulmonol       Date:  2020-10-07

Review 6.  Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations.

Authors:  Pedro A Pousa; Tamires S C Mendonça; Eduardo A Oliveira; Ana Cristina Simões-E-Silva
Journal:  J Pediatr (Rio J)       Date:  2020-09-22       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.